Effect of Sumac powder on Antioxidant indices and Uric Acid in women with polycystic ovary syndrome

Iran University of Medical Sciences0 个研究点目标入组 88 人开始时间: 待定最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•Patients with Polycystic ovary Syndrome based on two criteria of the three diagnostic criteria of the disease based on Rotterdam: 1.Bleeding is reduced or discontinued (as Delay more than 35 days or less than 8 bleeding episodes per year) 2. Clinical symptoms including hirsutism or Ferriman-Gallway (MGF) score above 8, acne and male pattern baldness and biochemical symptoms of increased androgenesis. 3. Polycystic ovary (12 or more of 12 follicles per ovary with a diameter of 2 to 9 mm, or an increase in ovarian volume to more than 310 ml). Patients with age between 20 to 40 years old.
•patient's acceptance of taking part in the study.

•Those who take drugs of anticoagulants and hyperlipidemia
•Use Tobacco
•Having kidney disease, diabetes, liver disease, cardiovascular disorders, hypothyroidism, inflammatory and rheumatic diseases, hyperprolactinemia, Cushing's syndrome, and congenital adrenal hyperplasia Follow a particular diet in the last three months.
•Take medications that affect insulin sensitivity, inflammation, or lipid profile and hormonal profile, including glucocorticoid drugs, ovulation induction drugs, anti-obesity, anti-diabetes, antihypertensive, estrogenic, anti-androgen, over the past 3 months
•Unwilling to participate in the study
•Use of Nutrition Supplements in the last 2 months
•Pregnancy or breastfeeding
•Sensitization or allergy to sumac

发起方